Reduced malignant glioblastoma recurrence post-resection through the anti-CD47 antibody and Temozolomide co-embedded in-situ hydrogel system
- Resource Type
- Article
- Source
- In
Journal of Controlled Release July 2023 359:224-233 - Subject
- Language
- ISSN
- 0168-3659